CA
CNCR

Calton & Associates’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Calton & Associates’s Portfolio CNCR Stock Details CNCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50
Closed -$1K – 501
2017
Q4 		$1K Buy
+50
New +$1K ﹤0.01% 1424